Biomarkers may help predict prostate cancer recurrence
June 19th, 2008 Posted in prostate cancer risksA scientific team from University of Texas Southwestern have identified seven biomarkers that may help predict prostate cancer recurrence in patients after surgery.
Biomarkers are proteins circulating in a patient’s blood that are specific to a disease.
Currently used risk assessment methods can predict prostate cancer recurrence with about 70 percent accuracy. This recent study revealed that with these newly identified biomarkers doctors will be able to predict recurrence and progression with 86 percent accuracy.